Publications
931
Citations
53,419
Est. group size
~24
Recurring co-author estimate
Active years
23
Publishing since 2003
Typically publishes in teams of ~21 · 6% small-team papers (≤3 authors) · across 45 venues
- Immune and Genomic Heterogeneity of MET-Altered Non–Small Cell Lung Cancer
JCO Precision Oncology · 2025
- Genomic and Immune Landscape of Non–Small Cell Lung Cancer Brain Metastases
JCO Precision Oncology · 2025
- A pathologist’s primer on implementing new standard-of-care molecular biomarker testing for precision prostate cancer management
American Journal of Clinical Pathology · 2025
- 975 POLE and TP53-Mutated Multiple Classifier Endometrial Carcinoma Shares Features of Immunogenicity and Low Copy Number with Tumors Containing Isolated POLE Mutations
Laboratory Investigation · 2025
- Abstract 2038: Antibody Drug Conjugates Treatment Response Score (ADC TRS) for predicting ADC treatment response
Cancer Research · 2025
- Evaluation of a predictive biomarker for antibody drug conjugates (ADCs).
Journal of Clinical Oncology · 2024
- Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).
Journal of Clinical Oncology · 2024
- Abstract 5101: Comparative genomic analysis reveals distinctive immune profiles in MET exon 14 mutated and MET amplified lung cancer
Cancer Research · 2024
- Abstract PO1-14-04: A multivariate biomarker to guide antibody-drug conjugate selection and provide insight on response differences across breast cancer subtypes
Cancer Research · 2024
- PP01.106 Validation of Immunotherapy Response Score (IRS) for Predicting Pembrolizumab Monotherapy Benefit in First Line (1L) Non-small cell lung cancer (NSCLC)
Journal of Thoracic Oncology · 2024
- Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit
Communications Medicine · 2023
- Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Cancer Research Communications · 2023
- Abstract 2171: A multivariate biomarker predicts sacituzumab govitecan response in solid tumors
Cancer Research · 2023
- Abstract 968: Evaluation of Her2 RNA expression as a potential predictive biomarker for anti-Her2 therapy
Cancer Research · 2023
- Supplementary Figure 2 from <i>TMPRSS2:ERG</i> Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
2023
- Journal of Clinical Oncology×42
- The Journal of Urology×28
- Cancer Research×24
- Modern Pathology×11
- Clinical Cancer Research×10
- Zachery R. Reichert
Medicine · University of Michigan
- Udit Singhal
Medicine · University of Michigan
- Lakshmi P. Kunju
Medicine · University of Michigan
- Alex K. Bryant
Medicine · University of Michigan
- Neil Vaishampayan
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile